Literature DB >> 17308252

Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients.

Alenka Spindler-Vesel1, Stig Bengmark, Irena Vovk, Ognjen Cerovic, Lidija Kompan.   

Abstract

BACKGROUND: Since the hepatosplanchnic region plays a central role in development of multiple-organ failure and infections in critically ill trauma patients, this study focuses on the influence of glutamine, peptide, and synbiotics on intestinal permeability and clinical outcome.
METHODS: One hundred thirteen multiple injured patients were prospectively randomized into 4 groups: group A, glutamine; B, fermentable fiber; C, peptide diet; and D, standard enteral formula with fibers combined with Synbiotic 2000 (Synbiotic 2000 Forte; Medifarm, Sweden), a formula containing live lactobacilli and specific bioactive fibers. Intestinal permeability was evaluated by measuring lactulose-mannitol excretion ratio on days 2, 4, and 7.
RESULTS: No differences in days of mechanical ventilation, intensive care unit stay, or multiple-organ failure scores were found between the patient groups. A total of 51 infections, including 38 pneumonia, were observed, with only 5 infections and 4 pneumonias in group D, which was significantly less than combined infections (p = .003) and pneumonias (p = .03) in groups A, B, and C. Intestinal permeability decreased only in group D, from 0.148 (0.056-0.240) on day 4 to 0.061 (0.040-0.099) on day 7; (p < .05). In group A, the lactulose-mannitol excretion ratio increased significantly (p < .02) from 0.050 (0.013-0.116) on day 2 to 0.159 (0.088-0.311) on day 7. The total gastric retention volume in 7 days was 1150 (785-2395) mL in group D, which was significantly more than the 410 (382-1062) mL in group A (p < .02), and 620 (337-1190) mL in group C (p < .03).
CONCLUSIONS: Patients supplemented with synbiotics did better than the others, with lower intestinal permeability and fewer infections.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17308252     DOI: 10.1177/0148607107031002119

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  53 in total

1.  Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial.

Authors:  Damien Barraud; Claire Blard; François Hein; Olivier Marçon; Aurélie Cravoisy; Lionel Nace; François Alla; Pierre-Edouard Bollaert; Sébastien Gibot
Journal:  Intensive Care Med       Date:  2010-05-26       Impact factor: 17.440

2.  Controversial results with use of probiotics in critical illness: contradictory findings from large multicenter trial.

Authors:  Jeremy R Stapleton; Stephen A McClave
Journal:  Curr Gastroenterol Rep       Date:  2009-08

3.  Controversial results with use of probiotics in critical illness: confirmation of early positive results.

Authors:  Jeremy R Stapleton; Stephen A McClave
Journal:  Curr Gastroenterol Rep       Date:  2009-08

Review 4.  Impact of Soluble Fiber in the Microbiome and Outcomes in Critically Ill Patients.

Authors:  Carla Venegas-Borsellino; Minkyung Kwon
Journal:  Curr Nutr Rep       Date:  2019-12

5.  Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial.

Authors:  Lee E Morrow; Marin H Kollef; Thomas B Casale
Journal:  Am J Respir Crit Care Med       Date:  2010-06-03       Impact factor: 21.405

Review 6.  Bugs or drugs: are probiotics safe for use in the critically ill?

Authors:  Lindsay M Urben; Jennifer Wiedmar; Erica Boettcher; Rodrigo Cavallazzi; Robert G Martindale; Stephen A McClave
Journal:  Curr Gastroenterol Rep       Date:  2014

Review 7.  Probiotics for preventing ventilator-associated pneumonia.

Authors:  Lulong Bo; Jinbao Li; Tianzhu Tao; Yu Bai; Xiaofei Ye; Richard S Hotchkiss; Marin H Kollef; Neil H Crooks; Xiaoming Deng
Journal:  Cochrane Database Syst Rev       Date:  2014-10-25

8.  Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.

Authors:  P D Cani; A M Neyrinck; F Fava; C Knauf; R G Burcelin; K M Tuohy; G R Gibson; N M Delzenne
Journal:  Diabetologia       Date:  2007-09-06       Impact factor: 10.122

Review 9.  Nutrition of the critically ill - emphasis on liver and pancreas.

Authors:  Stig Bengmark
Journal:  Hepatobiliary Surg Nutr       Date:  2012-12       Impact factor: 7.293

Review 10.  Prebiotics, probiotics, synbiotics in surgery--are they only trendy, truly effective or even dangerous?

Authors:  Nada Rayes; Daniel Seehofer; Peter Neuhaus
Journal:  Langenbecks Arch Surg       Date:  2008-12-16       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.